Hamish Baillie appointed a NED at Fidelity Special Values from 1 Jan 2026

Fidelity

Fidelity Special Values Plc (LON:FSV) has announced the appointment of Hamish Baillie as a non-executive Director of the Company with effect from 1 January 2026. Hamish will also serve as a member of the Audit, Management Engagement and Nomination Committees of the Board.

Hamish is non-executive Director and Senior Independent Director and Chairman of the Management Engagement Committee of The Biotech Growth Trust plc. He is also non-executive Director and Senior Independent Director of Mid Wynd International Investment Trust plc. He has extensive executive and non-executive experience in managing investment trusts.

Hamish’s executive career was spent at Ruffer LLP, which he joined in 2002 and became a partner in 2006. He was a member of the leadership team overseeing UK Wealth Management, including retail and platform investors. Between 2011 and 2022 he was the Lead Manager of Ruffer Investment Company Ltd.  He founded and managed the Edinburgh office of Ruffer and held firm-wide responsibilities in relation to portfolio management and investor communications.  He was also a director of Ruffer (Channel Islands) Limited.  He retired from Ruffer in October 2022.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Why the FTSE is holding steady as UK data weakens and global risks rise

The FTSE is steady despite weaker UK data, as investors respond to a stronger pound and rising global risks.

Outlook and strategy for UK investing in 2026

Alex Wright, portfolio manager of Fidelity Special Values PLC, sets out his outlook for 2026 and explains why UK equities continue to offer attractive valuation opportunities.

FTSE 100 reaches 10,000 as retail and energy stocks drive coordinated shift

The FTSE 100 has passed 10,000 with support from retail, energy and defence stocks.

Fidelity Special Values reports seventh consecutive monthly gain (LON:FSV)

Fidelity Special Values has released its November 2025 factsheet, reporting 12-month NAV and share price returns of 24.4% and 32.7% respectively, outperforming the benchmark amid a cautious but improving UK market backdrop.

FTSE 100 builds momentum as monetary outlook evolves

Investor attention is returning to the UK as the Bank of England signals a shift in direction, opening new tactical opportunities across the FTSE 100.

Defence stocks take the lead as investors pull back from consumer names

A sector rotation is taking shape in the FTSE, as defensive names and operational clarity draw renewed investor focus.

Search

Search